Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

REVEALED: 7 - The Real Truth

Indonesia bans syrup drugs after deadly kidney cases

JAKARTA: Indonesia has halted sales of medicinal syrup after 99 children died of acute kidney injuries this year.

Bangkok Post

Contaminated cough syrup from India linked to 70 child deaths. It's happened before

The World Health Organization has issued an alert about the deaths in the West African nation of Gambia. For context, we speak to the authors of The Truth Pill: The Myth of Drug Regulation in India.

WEKU

Indonesia bans cough syrup ingredients linked to child deaths

JAKARTA: Indonesia has banned ingredients linked to the deaths of 70 children in The Gambia from cough syrups as it investigates acute kidney damage that has killed more than 20 children in Jakarta this year.

Bangkok Post

From analysis to the latest developments in health,
read the most diverse news in one place.

Indonesia bans cough syrup material linked to Gambia child deaths

Indonesia on Saturday banned ingredients linked to the deaths of 70 children in Gambia from cough syrups in the Southeast Asian country as it investigates acute kidney damage that has killed more than 20 children in the capital Jakarta this year.

Reuters

Gambia says child deaths linked to cough syrup have risen to 70

Gambia's government on Friday said the number of child deaths from acute kidney injury, thought to be linked to Indian-made cough syrups, has risen to 70 from a previous toll of 69.

Reuters

India halts production at factory linked to Gambia 'cough syrup' deaths

In tonight's edition: The deaths of dozens of children in Gambia from suspected contaminated medicinal syrups sees Indian authorities shut down production at a pharmaceuticals company in Delhi. And the WHO hopes to start clinical trials for the strain of Ebola behind a deadly outbreak in Uganda. Finally, violent child…

France 24

Gambia cough syrup-related deaths | CDSCO to examine Maiden Pharma’s role, Haryana sends notice to firm

Haryana Health Minister Anil Vij said that authorities inspected a Maiden Pharmaceuticals factory in Sonepat and found 12 violations of good practices, following which production was ordered stopped

The Hindu

Read news from The Economist, FT, and more,
with one subscription

India finds violations at factory linked to Gambia children deaths -state minister

Authorities in India have stopped production of cough syrup at a factory linked to children's deaths in Gambia after they found violations, a state minister told Reuters partner ANI on Wednesday.

Reuters

Gambia police link child deaths to cough syrup imported by pharma firm

(This Oct. 11 story has been corrected to remove incorrect reference to pharmaceutical company based in United States in the first paragraph, and Atlanta in 4th & 5th paragraphs)

Reuters

Surge in Gambia child deaths linked cough syrup under control, president says

Gambia's President Adama Barrow on Friday said a surge in acute kidney injuries likely linked to a paracetamol syrup that killed dozens of children in past months was under control, with only two diagnoses in the last two weeks.

Reuters

Cough syrup deaths will impact India’s reputation of being ‘pharmacy of the world’, says Anand Sharma

Former Commerce and Industry Minister urges Centre to fix accountability

The Hindu

India News terms WHO alert on cough syrup deaths a conspiracy against India

“Bharat ke khilaaf syrup waali saazish,” announced the headline on India News during a morning segment and panel discussion over a recent global alert – issued after 66 deaths allegedly linked to four India-made cough syrups in Gambia.

Newslaundry

Morning Digest | Cough syrups linked to death of children exported only to the Gambia; Nine booked for performing pooja at madrasa in Karnataka’s Bidar, and more

A select list of stories to read before you start your day

The Hindu

Syrup shock: India has had own share of drug tragedies

MUMBAI: Some 66 deaths of children in Gambia after consumption of four cough syrups made by the Haryana-based Maiden Pharmaceuticals, the subsequent recall of the drugs by the West African country and a WHO alert have put the spotlight on quality monitoring and due diligence by companies, and the need…

The Times of India

Get all your
news in one place.

100's of premium titles.
One news app.

Edinburgh Live

Parents issued urgent cough medicine warning after 66 children die in The Gambia

The World Health Organisation says the contaminated medications may have been distributed outside of the West African country, and global exposure could well be ‘possible’.

The Hindu

Gambia deaths | Pharma exporters body asks Maiden to share details

The incident has left a serious dent in the reputation of Indian pharma industry and exports, says Director-General

Evening Standard

Global WHO alert over India-made cough syrups after deaths

The syrups could be linked to kidney damage as well as 66 deaths among children

Wales Online

World Health Organisation probes cough syrup's potential link to deaths of 60 children in Gambia

It is looking into reports that the medicine could cause kidney damage

Get all your
news in one place.

100's of premium titles.
One news app.

The Hindu

None of four cough syrups linked to death of 66 children in Gambia available for sale in India, say distributors

The Government of India has ordered a probe after WHO issued a warning about the drugs manufactured by Haryana-based pharmaceutical firm

Radio France Internationale

WHO warns against Indian-made cough remedies as 66 children die in Gambia

The World Health Organization has issued a warning that four cough and cold syrups produced by Maiden Pharmaceuticals in India could be linked to the deaths of 66 children in Gambia. The UN health agency says contaminated medication may have been distributed to other countries.

The Independent UK

Cough syrup warning after 66 children die in The Gambia

WHO says medications in question may have been distributed outside The Gambia

The Guardian - AU

Warning over cough syrups after 66 children die in the Gambia

WHO says the contaminated medications may have been distributed outside of the West African country, with global exposure ‘possible’

The Hindu

Drug regulator initiates probe after WHO links children deaths in Gambia to cough syrup made in India

Maiden Pharmaceutical Limited is the manufacturer licensed by the State drug controller for the products under reference, and holds manufacturing permission for these products

Reuters

India tests samples of cough syrup linked to deaths of children in Gambia

India said it is testing samples of cough syrups produced by local manufacturer Maiden Pharmaceuticals for export after the World Health Organization said its products were linked to the deaths of dozens of children in Gambia.

France 24

WHO issues alert after 66 children die after taking cough syrup in The Gambia

In tonight's edition: Several cough and cold syrups made in India are subject to a product alert after the deaths of 66 children in The Gambia. The WHO alert warns that the substances are toxic and is worried about global exposure. Also, anti-French and pro-Russian sentiment are present in Ouagadougou,…

1 … 6 7 8 9

People

Tedros Adhanom Ghebreyesus

538 stories

Abhishek Manu Singhvi

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

World Health Organisation

267 stories

UN Human Rights Council

66 stories

Ministry of Health and Family Welfare

Maiden Pharmaceuticals

12 stories

India News

11 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.